Grifols SA (GIKLY) stock
GIKLYOTCPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GRFS
$5.55+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.91BP/E 4.2Yield –
Grifols ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was €1.69B, up 3.9% from the year before. Over ten years it grew 3.9% a year on average. The highest annual figure on record is €1.69B in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €1.69B | +3.9% |
| FY2024 | Dec 31, 2024 | €1.63B | +32.7% |
| FY2023 | Dec 31, 2023 | €1.23B | +2.9% |
| FY2022 | Dec 31, 2022 | €1.19B | +25.0% |
| FY2021 | Dec 31, 2021 | €954.83M | -27.5% |
| FY2020 | Dec 31, 2020 | €1.32B | -8.1% |
| FY2019 | Dec 31, 2019 | €1.43B | +17.3% |
| FY2018 | Dec 31, 2018 | €1.22B | +0.3% |
| FY2017 | Dec 31, 2017 | €1.22B | +6.8% |
| FY2016 | Dec 31, 2016 | €1.14B | -1.6% |
| FY2015 | Dec 31, 2015 | €1.16B | – |
See a number that looks wrong?